Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RiceTec is a private agricultural biotechnology and seed company focused on developing, producing, and commercializing hybrid rice seed and related rice products. The company’s core business is improving rice productivity and sustainability through breeding, seed technology, and crop innovation rather than developing human therapeutics. RiceTec serves farmers in the United States and international rice markets, with a business model centered on commercial seed sales and agronomic innovation. It is often described as a leader in hybrid rice and has also been associated with consumer rice brands such as RiceSelect and Texmati. RiceTec appears to be backed by the Liechtenstein Group and remains an operating private company headquartered in Alvin, Texas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RiceTec.